Burden of Multiple Sclerosis Relapses Is Underappreciated, Study Says
News
The burden of moderate-to-severe relapses in multiple sclerosis (MS) patients is underappreciated, according to a study sponsored by the pharmaceutical company Mallinckrodt. Researchers discussed the findings at ... Read more